Key facts
- This page summarizes Daniel M. Hancock's Form 4 filing for Cryoport, Inc. (CYRX).
- 7 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 18:27.
Daniel M. Hancock - 09 Nov 2026 Form 4 Insider Report for Cryoport, Inc. (CYRX)
- Reporting relationship
- Director
- Issuer ticker
- CYRX
- Reported as of
- 09 Nov 2026
- Net transaction value
- -$1,502,976
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2026, 18:27:50 UTC
- Prior SEC filing
- 08 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel M. Hancock
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Daniel M. Hancock filed Form 4 for Cryoport, Inc. (CYRX) on 12 Nov 2026.
Change
- Previous filing in this sequence was filed on 08 Jun 2026.
- Current net transaction value: -$1,502,976.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001764017
Primary reporting owner
HANCOCK DANIEL M
- Relationship
- Director
- Address
- C/O CRYOPORT INC., 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD
- Signature
- /s/ Daniel M. Hancock
- Signature date
- 12 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYRX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +30,000
- Change %
- +43%
- Price
- $9.73*
- Shares after
- 99,052
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
CYRX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +23,830
- Change %
- +24%
- Price
- $12.65*
- Shares after
- 122,882
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
CYRX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +20,549
- Change %
- +17%
- Price
- $7.00*
- Shares after
- 143,431
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
CYRX
transaction
Common Stock
Sale
- Transaction value
- -$1,502,976
- Shares
- -74,379
- Change %
- -52%
- Price
- $20.21
- Shares after
- 69,052
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYRX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -30,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,000
- Exercise price
- $9.73
- Footnotes
- F1, F3
CYRX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -23,830
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,830
- Exercise price
- $12.65
- Footnotes
- F1, F4
CYRX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -20,549
- Change %
- -50%
- Price
- $0.000000*
- Shares after
- 20,549
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,549
- Exercise price
- $7.00
- Footnotes
- F1, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
This transaction occurred automatically pursuant to a trading plan adopted by the reporting person on May 27, 2026.
Footnote F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.47, inclusive.
Footnote F3
1/36 of the options vested on the 4th of each month for thirty-six months beginning on 1/4/2019.
Footnote F4
1/12 of the options vested on the 17th of the month for twelve months beginning 6/17/2024.
Footnote F5
1/12 of the options vested on the 6th of the month for twelve months beginning 7/6/2025.
SEC remarks
With respect to prices reported as weighted average prices in Table I, the reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.